HTG Molecular Diagnostics (HTGM) Reports Q4 Loss Per Share of $0.83

HTG Molecular Diagnostics (NASDAQ: HTGM) reported Q4 EPS of ($0.83), versus ($52.49) reported last year. Revenue for the quarter came in at $1.2 million, versus $810 thousand reported last year.

For earnings history and earnings-related data on HTG Molecular Diagnostics (HTGM) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Deere shares climb as fiscal Q3 earnings and revenue top estimates
• Walmart shares fall despite earnings beat